The 28 rating InvestorsObserver gives to Allovir Inc (ALVR) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 16 percent of stocks in the Biotechnology industry, ALVR’s 28 overall rating means the stock scores better than 28 percent of all stocks.
ALVR has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on ALVR!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Allovir Inc Stock Today?
Allovir Inc (ALVR) stock is higher by 1.75% while the S&P 500 has fallen -0.92% as of 10:10 AM on Thursday, Sep 21. ALVR is higher by $0.04 from the previous closing price of $2.28 on volume of 110,595 shares. Over the past year the S&P 500 has risen 15.09% while ALVR has fallen -69.71%. ALVR lost -$1.83 per share the over the last 12 months.
Click Here to get the full Stock Report for Allovir Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
